| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.068 | 0.1 |